Societies

The role of biomarkers in Chemotherapy-Induced Peripheral Neurotoxicity

Photo from Paola Alberti/LinkedIn

Jun 30, 2024, 12:25

The role of biomarkers in Chemotherapy-Induced Peripheral Neurotoxicity

Paola Alberti, Assistant Professor of Human Anatomy at the University of Milano-Bicocca, shared on LinkedIn:

“Yesterday I had the honour to be part of a workshop dedicated to dissect the role of biomarkers in Chemotherapy-Induced Peripheral Neurotoxicity (CIPN), during the 2024 The Multinational Association of Supportive Care in Cancer (MASCC) meeting in Lille, France.

I had the opportunity to discuss this fascinating topic with great experts. This first step will lead to many more efforts of a multidisciplinary group to push forward the use of biomarkers in CIPN.

I am mostly grateful to Professor Ellen Smith for inviting me and to all the incredibly knowledgeable colleagues I had the opportunity to work with!”

Source: Paola Alberti/LinkedIn

biomarkers cancer Chemotherapy-Induced Peripheral Neurotoxicity Ellen Smith MASCC24 OncoDaily Oncology Paola Alberti The Multinational Association of Supportive Care in Cancer

In Memory of Alan Rickman and His Battle with Prostate and Pancreatic Cancer

New Paper Alert: Systemic management of advanced HCC: an increasingly complex game

AC-satoreotide got FDA Orphan Drug Designation status for SCLC and MCC

Oncologist Near Me – Nazik Hammad: A Leader in Cancer Care, Medical Education, and Health Equity

Garo Armen - A Bold Call to Action: Embracing Real-Time Innovation in Pediatric Cancer